군유전체학 시퀀싱 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Metagenomics Sequencing Market size is expected to reach USD 15.44 Billion in 2034 from USD 3.54 Billion (2025) growing at a CAGR of 17.76% during 2026-2034.

The global metagenomics sequencing market is witnessing rapid growth due to increasing interest in studying microbial communities and their impact on health and the environment. Metagenomics sequencing enables the analysis of genetic material from environmental samples without the need for culturing organisms. This technology is widely used in healthcare, agriculture, and environmental research. The growing demand for advanced genomic tools and the rising focus on microbiome research are driving market expansion.

Key growth drivers include advancements in sequencing technologies and decreasing costs of genomic analysis. The increasing application of metagenomics in disease diagnosis, drug discovery, and environmental monitoring is further boosting demand. Collaborations between academic institutions and biotechnology companies are accelerating innovation. Additionally, the rising awareness about the role of microorganisms in human health and ecosystems is supporting market growth.

In the future, the metagenomics sequencing market is expected to grow significantly with continued advancements in genomics and bioinformatics. The development of faster and more accurate sequencing platforms will enhance research capabilities. Emerging markets are likely to offer substantial growth opportunities due to increasing investments in research and healthcare infrastructure. Furthermore, expanding applications in personalized medicine and environmental sustainability will drive market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Reagents & Consumables
• Instruments
• Sequencing Services
• Analysis & Data Interpretation Solutions

By Technology

• 16S rRNA Sequencing
• Shotgun Metagenomic Sequencing
• Whole-Genome Sequencing & De Novo Assembly
• Metatranscriptomics

By Workflow

• Sample Processing & Library Preparation
• Sequencing
• Data Processing & Analysis

By Application

• Drug Discovery
• Clinical Diagnostics
• Soil Microbiome Applications
• Industrial Applications
• Ecological & Environmental Applications
• Veterinary Applications
• Other Applications

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, PerkinElmer Inc, QIAGEN NV, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, BGI Group, Psomagen Inc, Eurofins Scientific SE, Azenta Inc formerly part of Brooks Automation Inc, Novogene Co Ltd, Zymo Research Corporation, Tecan Trading AG, IntegraGen SA, Microsynth AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL METAGENOMICS SEQUENCING MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sequencing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Analysis & Data Interpretation Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL METAGENOMICS SEQUENCING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. 16S rRNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Shotgun Metagenomic Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Whole-Genome Sequencing & De Novo Assembly Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Metatranscriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL METAGENOMICS SEQUENCING MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Sample Processing & Library Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Processing & Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL METAGENOMICS SEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Soil Microbiome Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Industrial Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Ecological & Environmental Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Veterinary Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL METAGENOMICS SEQUENCING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product & Service
  • 8.2.2 By Technology
  • 8.2.3 By Workflow
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product & Service
  • 8.3.2 By Technology
  • 8.3.3 By Workflow
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product & Service
  • 8.4.2 By Technology
  • 8.4.3 By Workflow
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product & Service
  • 8.5.2 By Technology
  • 8.5.3 By Workflow
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product & Service
  • 8.6.2 By Technology
  • 8.6.3 By Workflow
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL METAGENOMICS SEQUENCING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Illumina Inc
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 PerkinElmer Inc
  • 10.2.4 QIAGEN N.V
  • 10.2.5 Oxford Nanopore Technologies Plc
  • 10.2.6 Pacific Biosciences Of California Inc
  • 10.2.7 BGI Group
  • 10.2.8 Psomagen Inc
  • 10.2.9 Eurofins Scientific SE
  • 10.2.10 Azenta Inc. (formerly Part Of Brooks Automation Inc.)
  • 10.2.11 Novogene Co. Ltd
  • 10.2.12 Zymo Research Corporation
  • 10.2.13 Tecan Trading AG
  • 10.2.14 IntegraGen SA
  • 10.2.15 Microsynth AG